A Re-evaluation and Validation of Ontogeny Functions for Cytochrome P450 1A2 and 3A4 Based on In Vivo DataSALEM, Farzaneh; JOHNSON, Trevor N; ABDULJALIL, Khaled et al.Clinical pharmacokinetics. 2014, Vol 53, Num 7, pp 625-636, issn 0312-5963, 12 p.Article

Clinical Pharmacokinetics of Clopidogrel and Its Metabolites in Patients with Cardiovascular DiseasesKARAZNIEWICZ-ŁADA, Marta; DANIELAK, Dorota; BURCHARDT, Paweł et al.Clinical pharmacokinetics. 2014, Vol 53, Num 2, pp 155-164, issn 0312-5963, 10 p.Article

Drug metabolising enzyme polymorphisms in Middle- and Eastern-European Slavic populationsHUBACEK, Jaroslav A.Drug metabolism and drug interactions. 2014, Vol 29, Num 1, pp 29-36, issn 0792-5077, 8 p.Article

Evaluation and Optimisation of Current Milrinone Prescribing for the Treatment and Prevention of Low Cardiac Output Syndrome in Paediatric Patients After Open Heart Surgery Using a Physiology-Based Pharmacokinetic Drug-Disease ModelVOGT, Winnie.Clinical pharmacokinetics. 2014, Vol 53, Num 1, pp 51-72, issn 0312-5963, 22 p.Article

Exploring drug-protein interactions using the relationship between injection volume and capacity factorXINFENG ZHAO; QIAN LI; JIEJUN CHEN et al.Journal of chromatography. 2014, Vol 1339, pp 137-144, issn 0021-9673, 8 p.Article

Intrathecal delivery of protein therapeutics to the brain: A critical reassessmentCALIAS, Pericles; BANKS, William A; BEGLEY, David et al.Pharmacology & therapeutics (Oxford). 2014, Vol 144, Num 2, pp 114-122, issn 0163-7258, 9 p.Article

Modelling the Sitagliptin Effect on Dipeptidyl Peptidase-4 Activity in Adults with Haematological Malignancies After Umbilical Cord Blood Haematopoietic Cell TransplantationDE MENDIZABAL, Nieves Vélez; STROTHER, Robert M; FARAG, Sherif S et al.Clinical pharmacokinetics. 2014, Vol 53, Num 3, pp 247-259, issn 0312-5963, 13 p.Article

Mucin-based stationary phases as tool for the characterization of drug-mucus interactionGARGANO, Andrea F. G; LÄMMERHOFER, Michael; LÖNN, Hans et al.Journal of chromatography. 2014, Vol 1351, pp 70-81, issn 0021-9673, 12 p.Article

Predictive Value of CYP3A and ABCB1 Phenotyping Probes for the Pharmacokinetics of Sunitinib: the ClearSun StudyKLOTH, Jacqueline S. L; KLÜMPEN, Heinz-Josef; BENNINK, Roelof J et al.Clinical pharmacokinetics. 2014, Vol 53, Num 3, pp 261-269, issn 0312-5963, 9 p.Article

Reporting a Population Pharmacokinetic-Pharmacodynamic Study: A Journal's PerspectiveJAMSEN, Kris M; McLEAY, Sarah C; BARRAS, Michael A et al.Clinical pharmacokinetics. 2014, Vol 53, Num 2, pp 111-122, issn 0312-5963, 12 p.Article

Role of OATP-1B1 and/or OATP-1B3 in hepatic disposition of tyrosine kinase inhibitorsKHURANA, Varun; MINOCHA, Mukul; PAL, Dhananjay et al.Drug metabolism and drug interactions. 2014, Vol 29, Num 3, pp 179-190, issn 0792-5077, 12 p.Article

Why Dried Blood Spots Are an Ideal Tool for CYP1A2 PhenotypingDE KESEL, Pieter M. M; LAMBERT, Willy E; STOVE, Christophe P et al.Clinical pharmacokinetics. 2014, Vol 53, Num 8, pp 763-771, issn 0312-5963, 9 p.Article

Pharmacokinetic and Pharmacodynamic Drug Interactions with Ethanol (Alcohol)CHAN, Lingtak-Neander; ANDERSON, Gail D.Clinical pharmacokinetics. 2014, Vol 53, Num 12, pp 1115-1136, issn 0312-5963, 22 p.Article

Pharmacokinetics and Pharmacodynamics of Antiretrovirals in the Central Nervous SystemCALCAGNO, Andrea; DI PERRI, Giovanni; BONORA, Stefano et al.Clinical pharmacokinetics. 2014, Vol 53, Num 10, pp 891-906, issn 0312-5963, 16 p.Article

La pharmacogénétique en quelques définitions = Pharmacogenetics: an introductionLANCIA, P; DE BEAUMAIS, T. Adam; ELIE, V et al.Correspondances en onco-hématologie. 2014, Vol 9, Num 6, pp 194-197, issn 1954-4820, 4 p.Article

A Semiphysiological Population Pharmacokinetic Model for Dynamic Inhibition of Liver and Gut Wall Cytochrome P450 3A by VoriconazoleFRECHEN, Sebastian; JUNGE, Lisa; SAARI, Teijo I et al.Clinical pharmacokinetics. 2013, Vol 52, Num 9, pp 763-781, issn 0312-5963, 19 p.Article

Association between Common CYPIA2 Polymorphisms and Theophylline Metabolism in Non-smoking Healthy VolunteersLIQING WANG; ZHEYI HU; XUN DENG et al.Basic & clinical pharmacology & toxicology (Print). 2013, Vol 112, Num 4, pp 257-263, issn 1742-7835, 7 p.Article

Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokineticsMARTINEZ, Marilyn N; ANTONOVIC, Leposava; COURT, Michael et al.Drug metabolism reviews (Softcover ed.). 2013, Vol 45, Num 2, pp 218-230, issn 0360-2532, 13 p.Article

Clinical Pharmacokinetics of New-Generation Antiepileptic Drugs at the Extremes of Age: An UpdateITALIANO, Domenico; PERUCCA, Emilio.Clinical pharmacokinetics. 2013, Vol 52, Num 8, pp 627-645, issn 0312-5963, 19 p.Article

Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variationZANGER, Ulrich M; SCHWAB, Matthias.Pharmacology & therapeutics (Oxford). 2013, Vol 138, Num 1, pp 103-141, issn 0163-7258, 39 p.Article

Cytochrome P450 pharmacogenetics in African populationsALESSANDRINI, Marco; ASFAHA, Sahle; DODGEN, Tyren Mark et al.Drug metabolism reviews (Softcover ed.). 2013, Vol 45, Num 2, pp 253-275, issn 0360-2532, 23 p.Article

Disposition Pathway-Dependent Approach for Predicting Organic Anion-Transporting Polypeptide-Mediated Drug―Drug InteractionsHU, Zhe-Yi.Clinical pharmacokinetics. 2013, Vol 52, Num 6, pp 433-441, issn 0312-5963, 9 p.Article

Exploration of Optimal Dosing Regimens of Haloperidol, a D₂ Antagonist, via Modeling and Simulation Analysis in a D₂ Receptor Occupancy StudyLIM, Hyeong-Seok; SU JIN KIM; NOH, Yook-Hwan et al.Pharmaceutical research. 2013, Vol 30, Num 3, pp 683-693, issn 0724-8741, 11 p.Article

Impact of Impaired Renal Function on the Pharmacokinetics of the Antiepileptic Drug LacosamideCAWELLO, Willi; FUHR, Uwe; HERING, Ursula et al.Clinical pharmacokinetics. 2013, Vol 52, Num 10, pp 897-906, issn 0312-5963, 10 p.Article

Metabolism of 7-ethoxycoumarin, safrole, flavanone and hydroxyflavanone by cytochrome P450 2A6 variantsUNO, Tomohide; OBE, Yuichiro; OGURA, Chika et al.Biopharmaceutics & drug disposition. 2013, Vol 34, Num 2, pp 87-97, issn 0142-2782, 11 p.Article